C-reactive protein and risk of cardiovascular disease: evidence and clinical application.
about
Exposure to polycyclic aromatic hydrocarbons and serum inflammatory markers of cardiovascular diseaseEffect of the rs2259816 polymorphism in the HNF1A gene on circulating levels of c-reactive protein and coronary artery disease (the ludwigshafen risk and cardiovascular health study).High-sensitivity C-reactive protein predicts cardiovascular risk in diabetic and nondiabetic patients: effects of insulin-sensitizing treatment with pioglitazoneEffects of a pragmatic lifestyle intervention for reducing body mass in obese adults with obstructive sleep apnoea: a randomised controlled trial.Usefulness of C-reactive protein as a marker for prediction of future coronary events in the asian Indian population: Indian atherosclerosis research study.Lipoprotein associated phospholipase A(2): role in atherosclerosis and utility as a biomarker for cardiovascular risk.The serum high-sensitive C reactive protein and homocysteine levels to evaluate the prognosis of acute ischemic strokeEffects of omega-3 carboxylic acids on lipoprotein particles and other cardiovascular risk markers in high-risk statin-treated patients with residual hypertriglyceridemia: a randomized, controlled, double-blind trialSimvastatin plus ezetimibe: combination therapy for the management of dyslipidaemia.Potential mechanisms linking atherosclerosis and increased cardiovascular risk in COPD: focus on Sirtuins.Therapeutic effects of guggul and its constituent guggulsterone: cardiovascular benefits.Sarcopenic obesity and inflammation in the InCHIANTI study.Lipoprotein-associated phospholipase A2: role in atherosclerosis and utility as a cardiovascular biomarker.Definitions of and contributions to cardiovascular disease in systemic lupus erythematosus.Low-intensity Physical Activity is Associated with Lower Maternal Systemic Inflammation during Late PregnancyC-reactive protein: an independent predictor of cardiovascular disease in Aboriginal Australians.Serum C-reactive protein level and prehypertension in two Asian populations.Clinical features of Chinese coronary heart disease patients with chronic kidney disease.Gallic Acid Improves Health-Associated Biochemical Parameters and Prevents Oxidative Damage of DNA in Type 2 Diabetes Patients: Results of a Placebo-Controlled Pilot Study.Unexpected role of the human cytomegalovirus contribute to essential hypertension in the Kazakh Chinese population of Xinjiang.The Infection Hypothesis Revisited: Oral Infection and Cardiovascular Disease
P2860
Q23915092-6728B62D-66D6-49E1-8D54-0665F20122FCQ33742763-FF4DDE9A-F90F-40D3-9AA4-1C956C2C9E70Q33979763-2AFB0BCA-7548-4528-8B80-E06AACCFF078Q34022427-09C0ABC7-8A7F-4953-8C17-3345BBB1CBF1Q34341013-A27C1E9A-5B46-4942-B0D7-A0391D5FB543Q34890672-9D38D817-5152-4D3D-8D41-AC6E8699C1DBQ35843992-53CD135E-C466-4F89-99EF-B22BAA3994AEQ36019971-500A2024-D65F-4356-8BF2-D2CDD71C2980Q36040720-E4AFDEBC-0E43-4BC8-9BD7-9D1F5E145708Q37007407-C5ACDF85-DB0C-4340-864F-E4BB23A40A6DQ37031592-426E3087-3767-4181-8D09-BF17889B5950Q37104446-D08BD46C-EF0E-4AC6-9579-340924C71EDDQ37707415-FC40F935-0509-49BA-8010-83AC04D32A98Q38162490-CF4C16EE-B295-480D-81B4-B18A58DEA230Q41533349-45532608-E8D1-4B7C-BAA0-0031FF46B3E4Q42975010-7DFF90FE-06D1-45E3-AB21-63EDAEBF1523Q43717775-08DD93D3-432C-445A-A8D0-F3B4DD86F4E0Q44886498-FEAAA7B1-66A8-4C8F-BE95-842A44188665Q49377852-239D0932-F464-4DF7-9F53-7B5604587667Q55512532-1B8C9003-74AF-47D2-8237-F3322CFDD85AQ59041105-D65B9DCB-F7CC-453C-B62D-FF8B676F0409
P2860
C-reactive protein and risk of cardiovascular disease: evidence and clinical application.
description
2003 nî lūn-bûn
@nan
2003 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
C-reactive protein and risk of cardiovascular disease: evidence and clinical application.
@ast
C-reactive protein and risk of cardiovascular disease: evidence and clinical application.
@en
type
label
C-reactive protein and risk of cardiovascular disease: evidence and clinical application.
@ast
C-reactive protein and risk of cardiovascular disease: evidence and clinical application.
@en
prefLabel
C-reactive protein and risk of cardiovascular disease: evidence and clinical application.
@ast
C-reactive protein and risk of cardiovascular disease: evidence and clinical application.
@en
P2093
P2860
P1476
C-reactive protein and risk of cardiovascular disease: evidence and clinical application.
@en
P2093
Paul M Ridker
Peter P Toth
Shari S Bassuk
P2860
P2888
P304
P356
10.1007/S11883-003-0004-3
P577
2003-09-01T00:00:00Z